跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,798 条关于
“SHR-4610”
全部
2,798
临床试验
1,872
药物
671
机构
31
资讯
224
5天前
Hengrui Medicine Gains Clinical Trial Approval for Ten New Drugs, Including Weight Loss
去年
SHR-A1811 Demonstrates Promising Activity in HER2-Expressing Breast Cancer Subtypes
去年
SHR-A1921 Shows Promise in Platinum-Resistant Ovarian Cancer
去年
SHR-A1811 Plus Pyrotinib Shows Promising Efficacy in HER2-Positive Breast Cancer
去年
SHR-1701 Plus XELOX and Bevacizumab Shows Promise in Metastatic Colorectal Cancer
去年
Novel SHR-1701 Combination Therapy Shows Promise in Reducing Chemotherapy-Induced Myelosuppression for Gastric Cancer Patients
去年
SHR-1701 Plus Famitinib Shows Promise in Advanced Biliary Tract and Pancreatic Cancer
去年
Hengrui Pharma Presents 72 Studies at ASCO 2025, Demonstrating Broad Oncology Pipeline Impact
5个月前
Hengrui Pharma Receives Clinical Trial Approvals for Five Oncology Drugs Including Novel KRAS G12D Inhibitor
去年
IDEAYA Biosciences Licenses DLL3-Targeting ADC from Hengrui Pharma in $1B Deal
第 1 页,共 23 页
上一页
下一页